Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
1,585.00Prev. Close
1,602.60Volume
19,249Total traded value
3.05 CrUpper Circuit
1,923.10Lower Circuit
1,282.10Fundamentals
| Market Cap | ₹21,797Cr |
| ROE | 12.33% |
| P/E Ratio(TTM) | 53.06 |
| EPS(TTM) | 30.16 |
| P/B Ratio | 7.64 |
| Dividend Yield | 0.46% |
| Industry P/E | 34.99 |
| Book Value | 209.55 |
| Debt to Equity | 0.87 |
| Face Value | 1 |
Understand Fundamentals
Financials
About Eris Lifesciences
Eris Lifesciences is a leading Indian Pharmaceutical company focused on the domestic market for branded medicines, with a strong presence in specialty areas like anti-diabetes and cardiology. The company's core strategy revolves around specialty therapies, and it remains committed to providing science-led, outcome-driven healthcare solutions to patients across India. Ranked 20th in the Indian Pharmaceutical Market, it stands out as the youngest company among the Top-20.;
| Parent Organisation | Eris Lifesciences |
| Managing Director | Mr. Amit Bakshi |
| NSE Symbol | ERIS |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Torrent Pharmaceuticals | NA (0.00%) | 60.35 | ||
| Gland Pharma | NA (0.00%) | 41.17 | ||
| Ajanta Pharma | NA (0.00%) | 32.72 | ||
| Sai Life Sciences | NA (0.00%) | 75.36 |